We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Experts: Patient Advocacy Groups Can Help Speed Drug Development
Experts: Patient Advocacy Groups Can Help Speed Drug Development
June 21, 2005
Building relationships with patient advocacy groups can help pharmaceutical firms speed the drug-development process, including during the all-important clinical trial phases, experts told the Biotechnology Industry Organization (BIO) annual conference.